BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34034774)

  • 1. Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling.
    Cui X; Wang H; Wu X; Huo K; Jing X
    J Ovarian Res; 2021 May; 14(1):71. PubMed ID: 34034774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis.
    Zheng M; Tang L; Huang L; Ding H; Liao WT; Zeng MS; Wang HY
    Obstet Gynecol; 2010 Oct; 116(4):884-891. PubMed ID: 20859152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
    Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
    Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
    Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
    Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression.
    Jin W; Ye L
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34013367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyopherin α 2 promotes proliferation, migration and invasion through activating NF-κB/p65 signaling pathways in melanoma cells.
    Yang F; Li S; Cheng Y; Li J; Han X
    Life Sci; 2020 Jul; 252():117611. PubMed ID: 32243925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.
    Cui X; Su H; Yang J; Wu X; Huo K; Jing X; Zhang S
    J Ovarian Res; 2022 Feb; 15(1):23. PubMed ID: 35135596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis.
    He L; Ding H; Wang JH; Zhou Y; Li L; Yu YH; Huang L; Jia WH; Zeng M; Yun JP; Luo RZ; Zheng M
    PLoS One; 2012; 7(9):e42992. PubMed ID: 22962582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of DNA Methylation Involved in the Activation of Nuclear Karyopherin Alpha 2 Leading to Identify the Progression and Prognostic Significance Across Human Breast Cancer.
    Cui X; Jing X; Wu X; Xu J; Liu Z; Huo K; Wang H
    Cancer Manag Res; 2020; 12():6665-6677. PubMed ID: 32801900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
    Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
    Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.
    Ohhara Y; Kinoshita I; Suzuki A; Imagawa M; Taguchi J; Noguchi T; Takeuchi S; Shimizu Y; Seki H; Suzuki J; Dosaka-Akita H
    Oncology; 2022; 100(12):685-695. PubMed ID: 36273446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
    Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
    Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
    Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
    Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging roles of KPNA2 in cancer.
    Han Y; Wang X
    Life Sci; 2020 Jan; 241():117140. PubMed ID: 31812670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer.
    Tsai MM; Huang HW; Wang CS; Lee KF; Tsai CY; Lu PH; Chi HC; Lin YH; Kuo LM; Lin KH
    Oncotarget; 2016 Jun; 7(26):39511-39526. PubMed ID: 27078844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
    Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
    Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
    Wang CI; Chien KY; Wang CL; Liu HP; Cheng CC; Chang YS; Yu JS; Yu CJ
    Mol Cell Proteomics; 2012 Nov; 11(11):1105-22. PubMed ID: 22843992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.
    Shi C; Sun L; Liu S; Zhang E; Song Y
    Med Sci Monit; 2020 Mar; 26():e921087. PubMed ID: 32147666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
    Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
    Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.